Publication:
Leflunomide as a concomitant dmard choice for the biological treatment era of rheumatoid arthritis

Simple item page
dc.contributor.authorKimyon, Gezmiş
dc.contributor.authorKiraz, Sedat
dc.contributor.authorErtenli, İhsan
dc.contributor.authorKüçükşahin, Orhan
dc.contributor.authorDalkılıç, Ediz
dc.contributor.authorBeş, Cemal
dc.contributor.authorKanitez, Nilüfer Alpay
dc.contributor.authorKaşifoğlu, Timuçin
dc.contributor.authorEmmungil, Hakan
dc.contributor.authorCoşkun, Belkıs Nihan
dc.contributor.authorYağız, Burcu
dc.contributor.authorKoca, Süleyman Serdar
dc.contributor.authorÇınar, Muhammet
dc.contributor.authorAteş, Askin
dc.contributor.authorAkar, Servet
dc.contributor.authorBakırlı, Duygu Ersözlü
dc.contributor.authorYazısız, Veli
dc.contributor.authorBilge, Nazife Şule Yaşar
dc.contributor.authorTufan, Müge Aydın
dc.contributor.authorMercan, Rıdvan
dc.contributor.authorKaradağ, Ömer
dc.contributor.authorKeleşoğlu, Ayşe Bahar
dc.contributor.authorGercik, Onay
dc.contributor.authorÖz, Burak
dc.contributor.authorAkar, Zeynel Abidin
dc.contributor.authorYılmaz, Sedat
dc.contributor.authorTuran, Sezin
dc.contributor.authorPehlivan, Yavuz
dc.contributor.authorTerzioğlu, Ender
dc.contributor.authorKılıç, Levent
dc.contributor.authorErten, Şükran
dc.contributor.authorTekgöz, Emre
dc.contributor.authorTaşçılar, Koray
dc.contributor.authorKalyoncu, Umut
dc.contributor.buuauthorDALKILIÇ, HÜSEYİN EDİZ
dc.contributor.buuauthorCOŞKUN, BELKIS NİHAN
dc.contributor.buuauthorYAĞIZ, BURCU
dc.contributor.buuauthorPEHLİVAN, YAVUZ
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Ramotoloji Bölümü
dc.contributor.orcid0000-0003-0298-4157
dc.contributor.researcheridJQW-5031-2023
dc.contributor.researcheridAAG-7155-2021
dc.contributor.researcheridAAG-8227-2021
dc.contributor.researcheridCMF-4757-2022
dc.date.accessioned2024-07-25T07:41:02Z
dc.date.available2024-07-25T07:41:02Z
dc.date.issued2018-09-01
dc.descriptionBu çalışma, 19-24, Ocak 2018 tarihlerinde Chicago[Amerika]’da düzenlenen Annual Meeting of the American-College-of-Rheumatology (ACR) and Association-for-Rheumatology-Health-Professionals (ARHP) Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipAmer Coll Rheumatol
dc.description.sponsorshipAssoc Rheumatol Hlth Profess
dc.identifier.eissn2326-5205
dc.identifier.issn2326-5191
dc.identifier.urihttps://hdl.handle.net/11452/43431
dc.identifier.volume70
dc.identifier.wos000447268901084
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherWiley
dc.relation.journalArthritis & Rheumatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectRheumatology
dc.titleLeflunomide as a concomitant dmard choice for the biological treatment era of rheumatoid arthritis
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isAuthorOfPublication1613225c-2f43-4052-9f82-210c854edcf4
relation.isAuthorOfPublicationfaabfe30-a620-4cbe-8b6d-3db71b10ce0e
relation.isAuthorOfPublication02b3cfbb-e8e7-4a95-b025-294888ae9a91
relation.isAuthorOfPublication0075f2ae-ae8a-4690-bd46-128775e8efac
relation.isAuthorOfPublication.latestForDiscovery1613225c-2f43-4052-9f82-210c854edcf4

Files

Collections

Yeni Yayınlar